Results 141 to 150 of about 24,961 (203)

Approaches to managing ototoxicity in the workplace. [PDF]

Int J Audiol
Morata TC, Carlson K, Fuente A, Poling GL, Garinis A, Hullar T, Lee J, Pouyatos B, Sliwinska-Kowalska M, Dreisbach L, Stuehm H, Konrad-Martin D.   +11 more
europepmc   +1 more source

The influence of targeted therapies in the inner ear. [PDF]

Front Pharmacol
Bonilla T, DiFatta J, Bas Infante E, Goncalves S.   +3 more
europepmc   +1 more source

Sarsasapogenin protects hair cells from cisplatin-induced ototoxicity by attenuating apoptosis and ferroptosis via alleviating oxidative stress. [PDF]

Front Pharmacol
Chen Z, Xie T, Chen C, Lin T, Wu X, Chen Y, Lin Y, Luo X, Zeng C, Lin C.   +9 more
europepmc   +1 more source

Single-Nucleus Transcriptomics Uncovers Xaf1-Driven PANoptosis as a Therapeutic Target in Aminoglycoside-Induced Hearing Loss. [PDF]

Cell Prolif
Wang X, Xiao H, Wu J, Lin Y, Ao Y, Ye Z, Tan X, Kong F, Chen X, Chai R, Zhang S.   +10 more
europepmc   +1 more source

Mesoporous Silica Nanoparticles for Quercetin-Controlled Delivery to Protect Cisplatin-Induced Ototoxicity. [PDF]

ACS Appl Bio Mater
Shen M, Wang H, Liu J, Zhou Z, Wu X, Fan H, Du H, Qiu Y, Liu D, Ma D, Wang Y, Tang Z, Yang S, Zhang Y, Zhang T, Gao X.   +15 more
europepmc   +1 more source

The Role of Genetic and Non-Genetic Factors in the Occurrence of Cisplatin-Associated Ototoxicity. [PDF]

Int J Mol Sci
Iațentiuc A, Iațentiuc IM, Frăsinariu OE, Cozma SR, Bitere-Popa OR, Olariu R, Rădulescu LM, Ioniuc I, Cuciureanu M, Alecsa M, Guma C, Miron IC.   +11 more
europepmc   +1 more source

Early downregulation of hair cell (HC)-specific genes in the vestibular sensory epithelium during chronic ototoxicity. [PDF]

J Biomed Sci
Borrajo M, Greguske EA, Maroto AF, Palou A, Renner A, Giménez-Esbrí V, Sedano D, Gut M, Esteve-Codina A, Martín-Mur B, Barrallo-Gimeno A, Llorens J.   +11 more
europepmc   +1 more source

Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB. [PDF]

IJTLD Open
Souleymane MB, Decroo T, Soumana A, Lawan IM, Aboubacar AC, Gagara-Issoufou A, Moussa RH, Kabirou AA, Hamidou I, Moussa SH, Adamou M, Adehossi E, Mamadou S, de Jong BC, Rigouts L, Piubello A.   +15 more
europepmc   +1 more source

Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma. [PDF]

Sci Rep
Hambach B, Bilokon A, Lee J, Allemang LN, Chisholm J, Zalewski CK, Christensen J, Brewer CC, Gulley JL, Allen CT, Cunningham LL, Fernandez KA.   +11 more
europepmc   +1 more source

Connexins in Acquired Hearing Loss: Expanding Research Perspectives. [PDF]

Biomedicines
Huang S, Zhu J, Zhang J, Gong T, Fei Z, Chen P, Hou S, Yang J.   +7 more
europepmc   +1 more source